Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Cytokinetics Inc (NASDAQ: CYTK) closed at $36.67 down -1.82% from its previous closing price of $37.35. In other words, the price has decreased by -$1.82 from its previous closing price. On the day, 2.54 million shares were traded.
Ratios:
For a deeper understanding of Cytokinetics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.17 and its Current Ratio is at 6.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on April 24, 2025, initiated with a Overweight rating and assigned the stock a target price of $55.
On February 07, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $86.
On January 22, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $80.Stifel initiated its Buy rating on January 22, 2025, with a $80 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 05 ’25 when Callos Andrew sold 4,002 shares for $36.68 per share. The transaction valued at 146,793 led to the insider holds 60,687 shares of the business.
Blum Robert I sold 5,000 shares of CYTK for $204,800 on Apr 29 ’25. The President & CEO now owns 417,629 shares after completing the transaction at $40.96 per share. On Apr 22 ’25, another insider, Malik Fady Ibraham, who serves as the EVP Research & Development of the company, sold 2,000 shares for $38.11 each. As a result, the insider received 76,220 and left with 140,255 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 236.63.
Stock Price History:
Over the past 52 weeks, CYTK has reached a high of $68.44, while it has fallen to a 52-week low of $32.74. The 50-Day Moving Average of the stock is -12.18%, while the 200-Day Moving Average is calculated to be -26.02%.
Shares Statistics:
A total of 118.21M shares are outstanding, with a floating share count of 116.05M. Insiders hold about 2.64% of the company’s shares, while institutions hold 109.63% stake in the company.
